Bicara Therapeutics Ownership & Insider Activity

Bicara Therapeutics (BCAX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.2% of shares outstanding. Institutional investors hold 41.7%.

Shares Outstanding

66.173M

Shares Float

47.507M

Insider Shares Owned

783.031K

Insider % Owned

1.2%

Institutional Shares Held

27.586M

Institutional % Held

41.7%

Ownership Breakdown

Net Insider Activity by Month

Bicara Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 8, 2026	Ryan Cohlhepp	PRESIDENT, COO & INTERIM CEO	SELL-OPTIONS	—	$13.34	$334K
Aug 10, 2026	Ivan Hyep	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$15.88	$302K
Aug 10, 2026	Claire Mazumdar	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$15.88	$242K
Aug 10, 2026	Ryan Cohlhepp	PRESIDENT AND COO	SELL-OPTIONS	—	$15.88	$453K
Jul 10, 2026	Claire Mazumdar	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$16.10	$246K
Jul 8, 2026	Ryan Cohlhepp	PRESIDENT AND COO	SELL	10.000K	$16.38	$762K
Jul 8, 2026	Ivan Hyep	CHIEF FINANCIAL OFFICER	SELL	15.500K	$16.32	$760K
May 21, 2026	Ivan Hyep	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$12.11	$153K
May 18, 2026	Claire Mazumdar	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$11.91	$244K
May 15, 2026	Ryan Cohlhepp	PRESIDENT AND COO	SELL	4.500K	$12.04	$223K
Apr 27, 2026	David Raben	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$13.33	$105K
Apr 21, 2026	Ivan Hyep	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$13.40	$177K